Benitec Biopharma Limited Current Part of Debt

Current Part of Debt of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Current Part of Debt growth rates and interactive chart. Current debt or short-term debt are a firm's financial obligations that are expected to be paid off within a year. It also includes the portion of long-term debt that is due within a year. It is a part of the overall indebtedness of a company, and is included in Debt/Equity and Debt/Assets ratios.

Highlights and Quick Summary

  • Current Part of Debt for the quarter ending December 31, 2022 was $263 Thousand (a 1.94% increase compared to previous quarter)
  • Year-over-year quarterly Current Part of Debt increased by 13.36%
  • Annual Current Part of Debt for 2022 was $252 Thousand (a 18.31% increase from previous year)
  • Annual Current Part of Debt for 2021 was $213 Thousand (a 10.94% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Current Part of Debt of Benitec Biopharma Limited

Most recent Current Part of Debtof BNTC including historical data for past 10 years.

Interactive Chart of Current Part of Debt of Benitec Biopharma Limited

Benitec Biopharma Limited Current Part of Debt for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.26 $0.26 $0.25 $0.23 $0.25
2021 $0.21 $0.19 $0.21 $0.21 $0.21
2020 $0.2 $0.2 $0.19 – $0.19

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology
© stockrow.com